|
Canada-0-BAILIFFS företaget Kataloger
|
Företag Nyheter:
- GMP Peptide CDMO Oligo Manufacturing - Sinopep Biopharma
Sinopep-Allsino Biopharmaceutical Co , Ltd is a leading worldwide commercial API supplier and full-service CDMO, delivering large-scale GMP manufacturing for peptides, oligonucleotides, and small molecules to support global biopharma partners from development through commercial supply
- About Us - Sinopep Biopharma
At Sinopep, we are committed to advancing the frontiers of peptides, oligonucleotides, and small molecules as transformative therapeutic solutions As a leader in pharmaceutical research, development, and manufacturing, we aim to set new standards across the industry Our relentless focus on innovation, operational excellence, and scalable manufacturing has positioned us at the forefront of
- Contact Us - Sinopep Biopharma
Important Disclaimer and Purchaser Qualification Our research-grade and GMP-grade peptides, oligonucleotides, and small molecule products are not intended for individual or personal use and are available exclusively to approved organizations We sell these products solely to qualified pharmaceutical companies, biotechnology firms, research institutions, and licensed compounding pharmacies We
- News - Sinopep Biopharma
News All Sinopep News At Sinopep, we value media interest in our business, services, and capabilities You’re welcome to explore the resources on this page or contact our media relations team for specific inquiries We’ll make sure you’re connected with the appropriate business leader or subject matter expert
- Knowledge Center - Sinopep Biopharma
At Sinopep, we are committed to advancing the frontiers of peptides, oligonucleotides, and small molecules as transformative therapeutic solutions As a leader in pharmaceutical research, development, and manufacturing, we aim to set new standards across the industry Our relentless focus on innovation, operational excellence, and scalable manufacturing has positioned us at the forefront of
- Sinopep Company Overview Video
Sinopep leads the global market in large-scale production of key GLP-1 receptor agonists—ranking #1 in export volume With one of the world’s largest and most flexible manufacturing capacities, we support production from milligrams to over 200 kilograms per batch
- Press Releases - Sinopep Biopharma
At Sinopep, we value media interest in our business, services, and capabilities You’re welcome to explore the resources on this page or contact our media relations team for specific inquiries We’ll make sure you’re connected with the appropriate business leader or subject matter expert
- Discovery - Sinopep Biopharma
Discovery Peptide Oligonucleotide Partner Sinopep supports drug discovery teams with integrated CMC-informed peptide and oligonucleotide services, enabling efficient progression from early research through preclinical development Our discovery-driven approach helps de-risk programs and accelerate the transition to development-ready candidates
- Peptide, Oligonucleotide Small Molecule CDMO - Sinopep-Allsino . . .
Sinopep is a leading CDMO specializing in the development and GMP manufacturing of peptide, oligonucleotide, and small molecule NCEs With the rapidly expanding landscape of peptide therapeutics, we have grown our peptide CDMO platform into one of our most advanced and comprehensive capabilities, leveraging cutting-edge solid-phase and liquid-phase synthesis to tackle even the most complex and
- Generic APIs Brochure - Sinopep-Allsino Biopharmaceutical Co. , Ltd.
Generic APIs Brochure Sinopep specializes in the development and cGMP manufacturing of high-quality peptide, oligonucleotide, and small molecule active pharmaceutical ingredients (APIs) intended exclusively for further processing, R D, or compounding by licensed facilities in accordance with applicable laws and regulations
|
|